Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Senate bill would increase healthcare options for veterans

Sen. John McCain, R.-Ariz.,, fed-up with the slow pace of improvements in the Department of Veterans Affairs’ system, proposed legislation that would allow veterans to go anywhere for healthcare.

CMS rolls out MACRA regulation

CMS announced plans to replace its current meaningful use program for physicians participating in the Medicare program.

U of Chicago Medicine’s expansion criticized by state regulators

A $269 million expansion to add a new cancer and trauma center at the University of Chicago Medical Center may be too costly and could outpace local need for more beds

MassHealth hopes to transition to ACO to control costs

A proposed overhaul of Massachusetts’ Medicaid program, MassHealth, would transition the program from fee-for-service to an accountable care organization (ACO) model by 2017 in an effort to keep costs down.

Two Illinois hospitals battle over disclosing insurer agreements

Advocate Health Care is suing Palos Community Hospital over a request for access to Advocate’s rate agreements with insurers, though Advocate had asked for and received the same information from the Palos hospital.

Thumbnail

CMS issues final rule on Medicaid managed-care plans

New standards include an 85 percent medical-loss ratio (MLR) requirement, along with changes to behavioral health coverage.

Stanford Hospital nurses preparing to call strike

Three days of federal mediation failed to produce a deal with hospital administrators.

To control costs, it may be up to patients to 'pay the piper'

After many seemingly “routine” doctor’s appointments, many Americans receive their bill and try to make sense of the many ins-and-outs of deductibles, co-pays, reimbursement rules, and paperwork. They face a whirlwind of complexities that have nothing to do with buying healthcare.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.